(Q43774622)

26 November 2017

title

The long-term use of felbamate in children with severe refractory epilepsy (English)

1 reference

26 November 2017

M R Cilio

1

1 reference

26 November 2017

A I Kartashov

series ordinal

2

1 reference

26 November 2017

F Vigevano

series ordinal

3

1 reference

26 November 2017

publication date

1 November 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

47

1 reference

26 November 2017

issue

1-2

1 reference

26 November 2017

page(s)

1-7

1 reference

Effect of felbamate on plasma levels of carbamazepine and its metabolites

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Felbamate in refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Efficacy of felbamate in therapy for partial epilepsy in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Felbamate Increases Phenytoin but Decreases Carbamazepine Concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Felbamate for refractory infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Felbamate for partial seizures: results of a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Urinary retention related to phenytoin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Utilization of new antiepileptic drugs in children

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Felbamate monotherapy: controlled trial in patients with partial onset seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Carbamazepine-induced urinary retention in long-standing diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900290-X

7 January 2021

10.1016/S0920-1211(01)00290-X

Identifiers

DOI

1 reference

26 November 2017

1 reference